Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Registered products in the Philippines
1 product registered with the Food and Drug Administration (FDA) Philippines list Rotavirus vaccine as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
Rotasiil-LiquidRotavirus Vaccine, (Live Attenuated) | Formulation: Each dose (2 mL) contains: Live, Attenuated Bovine - Human Rotavirus Reassortant [G1, G2, G3, G4, and G9]* *Grown on Vero cells **FFU= Focus-forming Unit ***CCID= Cell culture infectious disease ≥105.6 FFU**/serotype (NLT 6.30 log10 CCID 50*** per dose) Oral SuspensionSingle dose. 5 mL (net content: 2 mL) LDPE plastic ampoule with Vaccine Vial Monitor (VVM) (Box of 1's an and 50's). | Rx | Serum Institute of India Private LimitedIndia | Faberco Life Sciences, Inc. | BR-1434 | Nov 28, 2027 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Formulary and coverage
| Philippine National Formulary | Listed as Rotavirus Vaccine |
| PNF listing | Live, attenuated, monovalent G1P[8] strain: 1.5 mL oral suspension (NLT 10^6.0 CCID50) in prefilled glass syringe |
| PNF listing | Live, attenuated, pentavalent G1, G2, G3, G4 and P1A[8] strains: 2 mL oral solution in single-dose plastic dosing tube |
| PNF listing | Live, attenuated, pentavalent G1, G2, G3, G4 and G9 strains (children under 1 year): 2 mL oral suspension in 5 mL single-dose LDPE ampoule |
| PhilHealth GAMOT | No |
Sources:
- PhilHealth Advisory No. 2025-0013, PNF 8th ed. EML 2019 as of November 2, 2022 with newly approved medicines as of January 27, 2025; DOH-DC No. 2024-0051 (included 2024-01-11); https://www.philhealth.gov.ph/advisories/2025/PA2025-0013.pdf, as of January 11, 2024
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
- PhilHealth Advisory No. 2025-0013, PNF 8th ed. EML 2019 as of November 2, 2022 with newly approved medicines as of January 27, 2025; DOH-DC No. 2024-0051 (included 2024-01-11); https://www.philhealth.gov.ph/advisories/2025/PA2025-0013.pdf
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .